Daikaffil Chemicals India has submitted revised consolidated financial results to BSE, including a Cash Flow Statement. This addresses a regulatory observation, but core financial figures remain unchanged.
Daikaffil Chemicals India Ltd Files Revised Consolidated Financial Results
Revised Consolidated Financial Results Filed
Consolidated Statement of Cash Flows Included
Reader Takeaway: Compliance gap addressed, no change in operational performance or financial health.
What just happened
Daikaffil Chemicals India Ltd has submitted revised consolidated financial results for the quarter ended March 31, 2026. The revision was made to include the Consolidated Statement of Cash Flows, a requirement that had previously led to a communication from the BSE regarding a potential fine.
Why this matters
This filing addresses a compliance issue raised by the stock exchange. While the company's revenue and net loss figures remain the same as previously reported, the inclusion of the cash flow statement provides a more complete financial picture and resolves a procedural gap.
The company reported revenue from operations of ₹1.97 crore and a net loss of ₹0.93 crore for the quarter ended March 31, 2026. Total assets stood at ₹9.42 crore and total equity at ₹6.78 crore as of that date.
The backstory
On June 30, 2026, Daikaffil Chemicals received a notice from the BSE concerning the non-submission of the Consolidated Statement of Cash Flows for the period ending March 31, 2026. The company's board reviewed this requirement and subsequently prepared the revised results.
What changes now
The company has successfully incorporated the Consolidated Statement of Cash Flows using the indirect method, reconciling opening standalone and closing consolidated statements as per Ind AS 7. Management has stated that this revision is purely for the cash flow statement and related disclosures.
Auditor's Report
The statutory auditor, N V C & Associates LLP, has issued an unmodified opinion on these revised consolidated financial results. The auditors confirmed that the revision was solely to add cash flow data and no new audit procedures were performed on other aspects of the financial statements.
Risks to watch
For investors, this event is primarily administrative. The core financial performance and position remain unchanged, so there is no direct impact on the company's operational health or financial standing. The key risk was the compliance failure, which has now been addressed.
Peer comparison
While not directly comparable due to the specific nature of this filing, other chemical companies typically provide detailed cash flow statements as part of their standard quarterly reporting. Daikaffil's revised filing brings it in line with these common practices.
Context metrics
For the quarter ended March 31, 2026:
- Revenue from Operations: ₹1.97 crore
- Net Loss: ₹0.93 crore
- Total Assets: ₹9.42 crore
What to track next
Investors should note that the company's financial performance and position remain as previously stated. The focus now shifts back to the company's core business operations and future financial reporting, ensuring all compliance requirements are met proactively.